Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet E Olson

Showing results (1-10 of 273) with videos related to

Pageof 28
Sort By:
Frontiers in Public Health|August 28, 2020
Mini-Review of Laboratory Operations in Biobanking: Building Biobanking Resources for Translational ResearchMine S Cicek, Janet E Olson
Journal of Epidemiology and Community Health|May 13, 2014
Validation of a population coronary disease predictive system: the CASSANDRA modelCindy A Kermott, Kent R Bailey, Janet E Olson
Mayo Clinic Proceedings|July 7, 2018
Understanding the Patterns of MultimorbidityJanet E Olson, Paul Y Takahashi, Jennifer M St Sauver
Biopreservation and Biobanking|July 29, 2024
Assessing Decisional Regret Among Biobank Sample DonorsSara Watson, Joel E Pacyna, Janet E Olson, et al.
Cancer Detection and Prevention|November 16, 2004
Bilateral oophorectomy and breast cancer risk reduction among women with a family historyJanet E Olson, Thomas A Sellers, Stephen J Iturria, et al.
Pharmacogenomics|September 25, 2025
Patient comprehension of preemptive pharmacogenomic resultsJoel E Pacyna, Suzette J Bielinski, Janet E Olson, et al.
Journal of Personalized Medicine|June 25, 2025
Patients' Concerns About Receiving Preemptive Pharmacogenomic Testing: Results from a Large, Longitudinal Survey of RIGHT Study ParticipantsJoel E Pacyna, Suzette J Bielinski, Janet E Olson, et al.
Pharmacogenomics and Personalized Medicine|May 14, 2021
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]Paul Y Takahashi, Euijung Ryu, James R Cerhan, et al.
BMC Medical Genomics|August 15, 2015
Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) studyIftikhar J Kullo, Hayan Jouni, Janet E Olson, et al.
Peerj|February 4, 2016
Impact of demographics on human gut microbial diversity in a US Midwest populationJun Chen, Euijung Ryu, Matthew Hathcock, et al.
Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:
Pageof 28
Frontiers in Public Health|August 28, 2020
Mini-Review of Laboratory Operations in Biobanking: Building Biobanking Resources for Translational ResearchMine S Cicek, Janet E Olson
Journal of Epidemiology and Community Health|May 13, 2014
Validation of a population coronary disease predictive system: the CASSANDRA modelCindy A Kermott, Kent R Bailey, Janet E Olson
Mayo Clinic Proceedings|July 7, 2018
Understanding the Patterns of MultimorbidityJanet E Olson, Paul Y Takahashi, Jennifer M St Sauver
Biopreservation and Biobanking|July 29, 2024
Assessing Decisional Regret Among Biobank Sample DonorsSara Watson, Joel E Pacyna, Janet E Olson, et al.
Cancer Detection and Prevention|November 16, 2004
Bilateral oophorectomy and breast cancer risk reduction among women with a family historyJanet E Olson, Thomas A Sellers, Stephen J Iturria, et al.
Pharmacogenomics|September 25, 2025
Patient comprehension of preemptive pharmacogenomic resultsJoel E Pacyna, Suzette J Bielinski, Janet E Olson, et al.
Journal of Personalized Medicine|June 25, 2025
Patients' Concerns About Receiving Preemptive Pharmacogenomic Testing: Results from a Large, Longitudinal Survey of RIGHT Study ParticipantsJoel E Pacyna, Suzette J Bielinski, Janet E Olson, et al.
Pharmacogenomics and Personalized Medicine|May 14, 2021
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]Paul Y Takahashi, Euijung Ryu, James R Cerhan, et al.
BMC Medical Genomics|August 15, 2015
Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) studyIftikhar J Kullo, Hayan Jouni, Janet E Olson, et al.
Peerj|February 4, 2016
Impact of demographics on human gut microbial diversity in a US Midwest populationJun Chen, Euijung Ryu, Matthew Hathcock, et al.
Pageof 28